2m 2m 2m 2m 2m 2m 2m
Tvardi Therap (TVRD)
NASDAQ
$3.13-$0.18 (-5.53%)
Price as of Jul 14, 2026 12:54 PM EDT- $31.1MMarket Cap
- -88.90%1-Year Change
- BiotechnologyIndustry
Tvardi Therap (TVRD)
$3.13-$0.18 (-5.53%)
TVRD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.31 | ||
Change | +$0.03 (+0.91%) | ||
Open | $3.20 | ||
High | $3.42 | ||
Low | $2.93 | ||
Previous Close | $3.28 | ||
Volume | 2,241,963 | ||
30-Day Average Volume | 6,850,480 | ||
1-Week Change | 64.68% | ||
1-Month Change | 25.38% | ||
1-Year Change | -88.90% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 9.4M | ||
Total Assets | $25.8M | ||
Market Cap | $31.1M | ||
Enterprise Value | $11.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$6.8M | ||
Free Cash Flow | -$5.9M | ||
EBIT | -$6.2M | ||
EBITDA | -$6.2M | ||
Net Working Capital | $14.1M | ||
EPS | -$0.73 | ||
Enterprise Value/EBITDA | -2 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -5 | ||
PEG | -0 | ||
Price/Free Cash Flow | -5 | ||
Price/Operating Cash Flow | -5 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue